{"id":"https://openalex.org/W2108056629","doi":"https://doi.org/10.3109/10428190903200790","title":"Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence","display_name":"Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence","publication_year":2009,"publication_date":"2009-10-03","ids":{"openalex":"https://openalex.org/W2108056629","doi":"https://doi.org/10.3109/10428190903200790","mag":"2108056629","pmid":"https://pubmed.ncbi.nlm.nih.gov/19821799"},"language":"en","primary_location":{"id":"doi:10.3109/10428190903200790","doi":"https://doi.org/10.3109/10428190903200790","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428190903200790","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044134864","display_name":"Koen van Besien","orcid":"https://orcid.org/0000-0002-8164-6211","observed_orcids":["https://orcid.org/0000-0002-8164-6211"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Koen van Besien","raw_affiliation_strings":["Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA. kvbesien@uchicago.edu","Section of Hematology/Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA. kvbesien@uchicago.edu","institution_ids":["https://openalex.org/I40347166"]},{"raw_affiliation_string":"Section of Hematology/Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065165100","display_name":"Alexander Dew","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Dew","raw_affiliation_strings":["Section of Hematology/Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shang Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shang Lin","raw_affiliation_strings":["Department of Health Studies"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Studies","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035169905","display_name":"Loren J. Joseph","orcid":"https://orcid.org/0000-0002-9503-4689","observed_orcids":["https://orcid.org/0000-0002-9503-4689"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Loren Joseph","raw_affiliation_strings":["Department of pathology, University of Chicago, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of pathology, University of Chicago, Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065240782","display_name":"Lucy A. Godley","orcid":"https://orcid.org/0000-0003-1914-9158","observed_orcids":["https://orcid.org/0000-0003-1914-9158"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lucy A. Godley","raw_affiliation_strings":["Section of Hematology/Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072420982","display_name":"Richard A. Larson","orcid":"https://orcid.org/0000-0001-9168-3203","observed_orcids":["https://orcid.org/0000-0001-9168-3203"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard A. Larson","raw_affiliation_strings":["Section of Hematology/Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031314202","display_name":"Toyosi Odenike","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toyosi Odenike","raw_affiliation_strings":["Section of Hematology/Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028012131","display_name":"Elizabeth Shima Rich","orcid":"https://orcid.org/0000-0002-3322-5359","observed_orcids":["https://orcid.org/0000-0002-3322-5359"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Rich","raw_affiliation_strings":["Section of Hematology/Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005939966","display_name":"Wendy Stock","orcid":"https://orcid.org/0000-0002-8349-9200","observed_orcids":["https://orcid.org/0000-0002-8349-9200"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wendy Stock","raw_affiliation_strings":["Section of Hematology/Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010645663","display_name":"Amittha Wickrema","orcid":"https://orcid.org/0000-0003-4035-3014","observed_orcids":["https://orcid.org/0000-0003-4035-3014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amittha Wickrema","raw_affiliation_strings":["Section of Hematology/Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057523501","display_name":"Andrew S. Artz","orcid":"https://orcid.org/0000-0003-0803-9607","observed_orcids":["https://orcid.org/0000-0003-0803-9607"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew S. Artz","raw_affiliation_strings":["Section of Hematology/Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5044134864"],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":null,"apc_paid":null,"fwci":4.2053,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.94330164,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"50","issue":"11","first_page":"1809","last_page":"1817"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12900","display_name":"Organ and Tissue Transplantation Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alemtuzumab","display_name":"alemtuzumab","score":0.8050000071525574},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9419999718666077},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.5590000152587891},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.7680000066757202},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.8410000205039978},{"id":"https://openalex.org/keywords/busulfan","display_name":"busulfan","score":0.8050000071525574},{"id":"https://openalex.org/keywords/clofarabine","display_name":"clofarabine","score":0.921999990940094},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.8289999961853027},{"id":"https://openalex.org/keywords/relapse-risk-prediction","display_name":"relapse risk prediction","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.9322681427001953},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.8431224226951599},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8075381517410278},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5822089910507202},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.5791168212890625},{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.5665928721427917},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5510421991348267},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5014722347259521},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4244893491268158},{"id":"https://openalex.org/C2779972918","wikidata":"https://www.wikidata.org/wiki/Q1194520","display_name":"Graft-versus-host disease","level":3,"score":0.41432806849479675},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.3851885497570038},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.20853188633918762},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.12461328506469727}],"mesh":[{"descriptor_ui":"D000074323","descriptor_name":"Alemtuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000912","descriptor_name":"Antibodies, Neoplasm","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017252","descriptor_name":"CD3 Complex","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018183","descriptor_name":"Transplantation Chimera","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019172","descriptor_name":"Transplantation Conditioning","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3109/10428190903200790","doi":"https://doi.org/10.3109/10428190903200790","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428190903200790","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:19821799","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19821799","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G2480078453","display_name":"Immunologic and pharmacologic studies in allotransplant","funder_award_id":"K24CA116471","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W82384675","https://openalex.org/W642647645","https://openalex.org/W1481603599","https://openalex.org/W1491993932","https://openalex.org/W1864748840","https://openalex.org/W1963551262","https://openalex.org/W1982912364","https://openalex.org/W1988866710","https://openalex.org/W1992492928","https://openalex.org/W2014751151","https://openalex.org/W2016017654","https://openalex.org/W2018246175","https://openalex.org/W2020296640","https://openalex.org/W2033971288","https://openalex.org/W2040775233","https://openalex.org/W2043591543","https://openalex.org/W2051925314","https://openalex.org/W2055034746","https://openalex.org/W2061033918","https://openalex.org/W2069783189","https://openalex.org/W2071104756","https://openalex.org/W2073140442","https://openalex.org/W2074588389","https://openalex.org/W2076272123","https://openalex.org/W2087388882","https://openalex.org/W2095284909","https://openalex.org/W2095808739","https://openalex.org/W2096793413","https://openalex.org/W2128185637","https://openalex.org/W2130695394","https://openalex.org/W2131706663","https://openalex.org/W2144037167","https://openalex.org/W2153431188","https://openalex.org/W2165628873","https://openalex.org/W2379365975","https://openalex.org/W2590512007","https://openalex.org/W2618073389","https://openalex.org/W2916269123"],"related_works":["https://openalex.org/W2073746315","https://openalex.org/W2556411965","https://openalex.org/W2291710263","https://openalex.org/W2509067812","https://openalex.org/W2550272059","https://openalex.org/W2586321810","https://openalex.org/W2592727353","https://openalex.org/W2329213947","https://openalex.org/W1516338784","https://openalex.org/W7127292517"],"abstract_inverted_index":{"We":[0],"analyzed":[1],"the":[2,86,219],"kinetics":[3],"of":[4,37,80,109,116,139,157,163,205,211,222],"CD3":[5,87,144],"chimerism":[6,52,145,191],"in":[7,29,85,143],"120":[8],"consecutive":[9],"allogeneic":[10],"hematopoietic":[11],"cell":[12],"transplantation":[13],"(HCT)":[14],"recipients":[15],"receiving":[16],"alemtuzumab-based":[17],"conditioning.":[18],"Fifty-two":[19],"received":[20,23,27],"fludarabine/melphalan,":[21],"44":[22],"fludarabine/busulfan,":[24],"and":[25,71,97,114,134,149,178,195,224],"24":[26],"clofarabine/melphalan":[28],"addition":[30],"to":[31,92,98,183,218],"alemtuzumab.":[32],"Post-transplant":[33],"GVHD":[34,118],"prophylaxis":[35],"consisted":[36],"tacrolimus.":[38],"No":[39],"prophylactic":[40],"donor":[41,51,190],"lymphocyte":[42],"infusion":[43],"or":[44,129],"other":[45],"interventions":[46],"were":[47,62],"used":[48,182],"for":[49,105,153,176],"mixed":[50],"(MDC).":[53],"Bone":[54],"marrow":[55],"(BM)":[56],"and/or":[57],"peripheral":[58],"blood":[59],"(PB)":[60],"samples":[61],"obtained":[63],"at":[64],"30":[65,148,194],"days,":[66,68,70],"100":[67],"180":[69,151,197],"1":[72],"year":[73],"following":[74],"HCT.":[75],"On":[76],"Day":[77,95,101,147,150,193,196],"30,":[78],"15%":[79,142],"assessable":[81],"patients":[82],"had":[83,90],"MDC":[84,103,122,164,212],"compartment.":[88],"This":[89],"increased":[91,203],"50%":[93],"by":[94,100,170],"100,":[96],"63%":[99],"180.":[102],"predicted":[104,152],"a":[106,154,173,201],"lower":[107],"risk":[108,156,174,204,221],"acute":[110,223],"(p":[111,119,131],"=":[112,120,132],"0.08)":[113],"particularly":[115],"chronic":[117,225],"0.01).":[121],"was":[123],"not":[124,169,180],"associated":[125,199],"with":[126,200],"subsequent":[127,158],"relapse":[128,177],"TRM":[130],"0.67":[133],"0.72,":[135],"respectively).":[136],"A":[137],"decline":[138],"more":[140],"than":[141],"between":[146,192],"40%":[155],"disease":[159,206],"recurrence.":[160,207],"The":[161,208],"observation":[162],"after":[165,213],"alemtuzumab":[166,214],"conditioning":[167,216],"does":[168],"itself":[171],"constitute":[172],"factor":[175],"should":[179],"be":[181],"guide":[184],"therapeutic":[185],"intervention.":[186],"By":[187],"contrast,":[188],"declining":[189],"is":[198],"somewhat":[202],"high":[209],"incidence":[210],"containing":[215],"contributes":[217],"low":[220],"GVHD.":[226]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}